AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment

Evanthia T. Roussos; Zuzana Keckesova; John D. Haley; David M. Epstein; Robert A. Weinberg; John S. Condeelis

doi:10.1158/0008-5472.CAN-10-1208

AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment

Evanthia T. Roussos, Zuzana Keckesova, John D. Haley, David M. Epstein, Robert A. Weinberg, John S. Condeelis

Cell Biology

Research output: Contribution to journal › Article › peer-review

74 Scopus citations

Abstract

Epithelial-mesenchymal transition (EMT) is a developmental program implicated in cancer progression and was the subject of the 2010 AACR meeting on the topic of EMT and Cancer Progression and Treatment held on February 28 to March 2 in Arlington, Virginia. A review of the involvement of EMT in gastrulation, organogenesis, carcinogenesis, and metastatic progression elucidated the overlap of EMT in these physiologic and pathologic conditions. Both novel and traditional markers of cells undergoing EMT were discussed and compared with features used to define cancer stem cells. Importantly, these defining characteristics of cells undergoing EMT were discussed in the context of therapeutic and prognostic developments.

Original language	English (US)
Pages (from-to)	7360-7364
Number of pages	5
Journal	Cancer research
Volume	70
Issue number	19
DOIs	https://doi.org/10.1158/0008-5472.CAN-10-1208
State	Published - Oct 1 2010

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/0008-5472.CAN-10-1208

Cite this

@article{75a40f21e3394500be69286417703ee2,

title = "AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment",

abstract = "Epithelial-mesenchymal transition (EMT) is a developmental program implicated in cancer progression and was the subject of the 2010 AACR meeting on the topic of EMT and Cancer Progression and Treatment held on February 28 to March 2 in Arlington, Virginia. A review of the involvement of EMT in gastrulation, organogenesis, carcinogenesis, and metastatic progression elucidated the overlap of EMT in these physiologic and pathologic conditions. Both novel and traditional markers of cells undergoing EMT were discussed and compared with features used to define cancer stem cells. Importantly, these defining characteristics of cells undergoing EMT were discussed in the context of therapeutic and prognostic developments.",

author = "Roussos, {Evanthia T.} and Zuzana Keckesova and Haley, {John D.} and Epstein, {David M.} and Weinberg, {Robert A.} and Condeelis, {John S.}",

year = "2010",

month = oct,

day = "1",

doi = "10.1158/0008-5472.CAN-10-1208",

language = "English (US)",

volume = "70",

pages = "7360--7364",

journal = "Cancer research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "19",

}

TY - JOUR

T1 - AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment

AU - Roussos, Evanthia T.

AU - Keckesova, Zuzana

AU - Haley, John D.

AU - Epstein, David M.

AU - Weinberg, Robert A.

AU - Condeelis, John S.

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Epithelial-mesenchymal transition (EMT) is a developmental program implicated in cancer progression and was the subject of the 2010 AACR meeting on the topic of EMT and Cancer Progression and Treatment held on February 28 to March 2 in Arlington, Virginia. A review of the involvement of EMT in gastrulation, organogenesis, carcinogenesis, and metastatic progression elucidated the overlap of EMT in these physiologic and pathologic conditions. Both novel and traditional markers of cells undergoing EMT were discussed and compared with features used to define cancer stem cells. Importantly, these defining characteristics of cells undergoing EMT were discussed in the context of therapeutic and prognostic developments.

AB - Epithelial-mesenchymal transition (EMT) is a developmental program implicated in cancer progression and was the subject of the 2010 AACR meeting on the topic of EMT and Cancer Progression and Treatment held on February 28 to March 2 in Arlington, Virginia. A review of the involvement of EMT in gastrulation, organogenesis, carcinogenesis, and metastatic progression elucidated the overlap of EMT in these physiologic and pathologic conditions. Both novel and traditional markers of cells undergoing EMT were discussed and compared with features used to define cancer stem cells. Importantly, these defining characteristics of cells undergoing EMT were discussed in the context of therapeutic and prognostic developments.

UR - http://www.scopus.com/inward/record.url?scp=77957375136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957375136&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-10-1208

DO - 10.1158/0008-5472.CAN-10-1208

M3 - Article

C2 - 20823151

AN - SCOPUS:77957375136

SN - 0008-5472

VL - 70

SP - 7360

EP - 7364

JO - Cancer research

JF - Cancer research

IS - 19

ER -

AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this